Skip to content
This search input has a predictive search function. When 3 letters or more are entered, a number of predictive results appear in a dropdown. Use arrow keys to navigate and use the enter key to go to the page highlighted.
    RENEW JOIN
    Dashboard

    Vagal nerve stimulation (VNS) white paper

    Vagal Nerve Stimulation (VNS) White Paper Approved by the Joint Reference Committee, June 2009 Approved by the APA Corresponding Committee on ECT and Other Electromagnetic Therapies, June 2008

    • 2009
    Click here to Download 28 KB

    Vagal Nerve Stimulation (VNS) White Paper
    Approved by the Joint Reference Committee, June 2009
    Approved by the APA Corresponding Committee on ECT
    and Other Electromagnetic Therapies, June 2008

    Vagal nerve stimulation for treatment resistant epilepsy has been available in the United States since 1997, and improved mood noted in epilepsy patients led to studies examining the use of VNS for treatment resistant depression. VNS implantation consists of placement of the stimulator in the chest wall that is attached by wires tunneled through the skin to the left vagus nerve in the carotid sheath. Potential side effects include voice alteration, hoarseness, coughing, paresthesia, dyspnea and rarely vocal cord paralysis and infection1.

    Medical leadership for mind, brain and body.

    Join Today